127 related articles for article (PubMed ID: 7632796)
1. "Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptors.
Jacobson KA; Fischer B; Ji XD
Bioconjug Chem; 1995; 6(3):255-63. PubMed ID: 7632796
[TBL] [Abstract][Full Text] [Related]
2. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Jacobson KA; Stiles GL; Ji XD
Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
[TBL] [Abstract][Full Text] [Related]
3. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
Stiles GL; Jacobson KA
Mol Pharmacol; 1988 Dec; 34(6):724-8. PubMed ID: 3200248
[TBL] [Abstract][Full Text] [Related]
4. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
[TBL] [Abstract][Full Text] [Related]
5. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
6. TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A
Jacobson KA; Olah ME; Stiles GL
Pharmacol Commun; 1992; 1(2):145-154. PubMed ID: 25374448
[TBL] [Abstract][Full Text] [Related]
7. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.
Ji XD; Stiles GL; van Galen PJ; Jacobson KA
J Recept Res; 1992; 12(2):149-69. PubMed ID: 1583620
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
Rosati AM; Traversa U
Biochem Pharmacol; 1999 Aug; 58(4):623-32. PubMed ID: 10413299
[TBL] [Abstract][Full Text] [Related]
10. Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.
Zhang J; Belardinelli L; Jacobson KA; Otero DH; Baker SP
Mol Pharmacol; 1997 Sep; 52(3):491-8. PubMed ID: 9281612
[TBL] [Abstract][Full Text] [Related]
11. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
13. Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.
Kennedy AP; Mangum KC; Linden J; Wells JN
Mol Pharmacol; 1996 Oct; 50(4):789-98. PubMed ID: 8863823
[TBL] [Abstract][Full Text] [Related]
14. Analysis of agonist-antagonist interactions at A1 adenosine receptors.
Leung E; Jacobson KA; Green RD
Mol Pharmacol; 1990 Jul; 38(1):72-83. PubMed ID: 2115114
[TBL] [Abstract][Full Text] [Related]
15. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
Patel A; Craig RH; Daluge SM; Linden J
Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
[TBL] [Abstract][Full Text] [Related]
16. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.
Jacobson KA; Ukena D; Kirk KL; Daly JW
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4089-93. PubMed ID: 3012550
[TBL] [Abstract][Full Text] [Related]
17. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
Scammells PJ; Baker SP; Belardinelli L; Olsson RA
J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
[TBL] [Abstract][Full Text] [Related]
18. A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
Stiles GL; Jacobson KA
Mol Pharmacol; 1987 Aug; 32(1):184-8. PubMed ID: 3614192
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
[TBL] [Abstract][Full Text] [Related]
20. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors.
Lohse MJ; Klotz KN; Lindenborn-Fotinos J; Reddington M; Schwabe U; Olsson RA
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):204-10. PubMed ID: 2825043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
